We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GOSS market cap is 231.14M. The company's latest EPS is USD -0.7935 and P/E is -1.29.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 95.84M | 9.48M |
| Operating Income | -40.49M | -49.03M | -41.96M | 52.09M | -33.92M |
| Net Income | -40.01M | -48.15M | -41.93M | 49.23M | -30.8M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 799k | 0 | 0 |
| Operating Income | -186.14M | -233.96M | -215.33M | -218.59M | -183.76M |
| Net Income | -180.31M | -243.36M | -234M | -229.38M | -179.82M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 347.93M | 311.92M | 259.36M | 373.45M | 350.88M |
| Total Liabilities | 243.31M | 249.15M | 232.64M | 291.92M | 296.74M |
| Total Equity | 104.62M | 62.77M | 26.72M | 81.53M | 54.14M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 426.6M | 539.43M | 343.66M | 272.45M | 311.92M |
| Total Liabilities | 74.12M | 218.75M | 222.19M | 260.37M | 249.15M |
| Total Equity | 352.49M | 320.68M | 121.46M | 12.08M | 62.77M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -125.73M | -159.16M | -52.3M | 64.05M | 32.01M |
| Investing | -96.6M | -110.97M | 61.67M | 2.56M | -24.19M |
| Financing | 193.06M | 190.15M | -2.56M | -11.77M | -11.49M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -144.83M | -176.36M | -188.89M | -187.03M | -159.16M |
| Investing | -147.14M | 215.34M | -117.43M | -1.04M | -110.97M |
| Financing | 321.58M | 312.54M | 3.33M | 117.09M | 190.15M |
| Market Cap | 231.14M |
| Price to Earnings Ratio | -1.29 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 7.2 |
| Price to Book Ratio | 3.68 |
| Dividend Yield | - |
| Shares Outstanding | 226.6M |
| Average Volume (1 week) | 818.15k |
| Average Volume (1 Month) | 792.83k |
| 52 Week Change | 24.18% |
| 52 Week High | 1.60 |
| 52 Week Low | 0.4993 |
| Spread (Intraday) | 0.09 (8.82%) |
| Company Name | Gossamer Bio Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.gossamerbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
